机构：[1]Department of Critical Medicine, School of Medicine, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen, Guangdong, China.深圳市康宁医院深圳市人民医院深圳医学信息中心[2]NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.[3]College of Integrative Medicine, Laboratory of Pathophysiology, Key Laboratory of Integrative Medicine on Chronic Diseases, Fujian University of Traditional Chinese Medicine, Fuzhou, China.[4]State Key Laboratory for Quality Assurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.[5]School of Medicine, Zhongda Hospital, Southeast University, Nanjing, China.[6]Central Laboratory, Shanxi Province Hospital of Traditional Chinese Medicine, Taiyuan, China.[7]Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.[8]State Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan University, Kaifeng, Henan, China.
National Natural Science Foundation of China,
Grant/Award Numbers: 32101219, 82373775;
Shenzhen Science and Technology Innovation
Committee, Grant/Award Numbers:
RCBS20210706092213007,
RCYX20221008092950121; Shenzhen People's Hospital, Grant/Award Number:
SYWGSCGZH202304; National Key Research
and Development Program of China,
Grant/Award Numbers: 2020YFA0908000,
2022YFC2303600; Science and Technology
Foundation of Shenzhen,
Grant/Award Number:
JCYJ20210324115800001; HUILAN Public
Welfare; Shenzhen Science and Technology
Innovation Commission,
Grant/Award Numbers:
JCYJ20200109120205924,
JCYJ20210324113608023; GuangDong Basic
and Applied Basic Research Foundation,
Grant/Award Number: 2021A1515012164;
International Science and Technology
Cooperation for Shenzhen Technology
Innovation Plan, Grant/Award Number:
GJHZ20200731095411034; Chinese
Postdoctoral Science Foundation,
Grant/Award Number: 2022M712190;
Innovation Team and Talents Cultivation
Program of the National Administration of
Traditional Chinese Medicine,
Grant/Award Number: ZYYCXTD‐C‐202002;
Shenzhen Medical Research Fund,
Grant/Award Number: B2302051;
Distinguished Expert Project of Sichuan
Province Tianfu Scholar, Grant/Award Number:
CW202002; CACMS Innovation Fund,
Grant/Award Number: CI2023E002; Natural
Science Foundation of Shenzhen City, China,
Grant/Award Number:
KCXFZ20201221173600001; State Key
Laboratory for Quality Assurance and
Sustainable Use of Daodi Herbs
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|3 区医学
小类|3 区病毒学
最新[2025]版：
大类|3 区医学
小类|3 区病毒学
第一作者：
第一作者机构：[1]Department of Critical Medicine, School of Medicine, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen, Guangdong, China.[2]NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
共同第一作者：
通讯作者：
通讯机构：[1]Department of Critical Medicine, School of Medicine, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen, Guangdong, China.[2]NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.[4]State Key Laboratory for Quality Assurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.[6]Central Laboratory, Shanxi Province Hospital of Traditional Chinese Medicine, Taiyuan, China.[7]Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.[8]State Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan University, Kaifeng, Henan, China.[*1]Central Laboratory, Shanxi Province Hospital of Traditional Chinese Medicine, Taiyuan 030012, China.[*2]Department of Critical Medicine, School of Medicine, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen, Guangdong 518020, China[*3]NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
推荐引用方式(GB/T 7714)：
Zheng Liuhai,Wang Huifang,Liu Xueyan,et al.A panel of multivalent nanobodies broadly neutralizing Omicron subvariants and recombinant[J].Journal Of Medical Virology.2024,96(3):e29528.doi:10.1002/jmv.29528.
APA：
Zheng Liuhai,Wang Huifang,Liu Xueyan,Xu Chengchao,Tian Mingxiong...&Liu Shuwen.(2024).A panel of multivalent nanobodies broadly neutralizing Omicron subvariants and recombinant.Journal Of Medical Virology,96,(3)
MLA：
Zheng Liuhai,et al."A panel of multivalent nanobodies broadly neutralizing Omicron subvariants and recombinant".Journal Of Medical Virology 96..3(2024):e29528
